Citation: | Zhi-Nan LU, Mario Evora, Edmundo Lao, Man Ieng Pun, Weng Hong Pun, Monica Pon, Kong Chu, Pui I Ieong, Toi-Meng Mok, Yong-Jian WU. The aging burden of hospitalization for heart failure in Chinese populations: evidence from the Macao Heart Failure Study. J Geriatr Cardiol 2020; 17(9): 533-543. doi: 10.11909/j.issn.1671-5411.2020.09.008 |
[1] |
Writing Committee M, Acc/Aha Task Force M. 2016 ACC/ AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Card Fail 2016; 22: 659–669. doi: 10.1016/j.cardfail.2016.07.001
|
[2] |
van der Meer P, Gaggin HK, Dec GW. ACC/AHA versus ESC Guidelines on Heart Failure: JACC Guideline Comparison. J Am Coll Cardiol 2019; 73: 2756–2768. https://www.sciencedirect.com/science/article/pii/S0735109719346996
|
[3] |
Driver JA, Djousse L, Logroscino G, et al. Incidence of cardiovascular disease and cancer in advanced age: prospective cohort study. BMJ 2008; 337: a2467. doi: 10.1136/bmj.a2467
|
[4] |
Bleumink GS, Knetsch AM, Sturkenboom MC, et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. Eur Heart J 2004; 25: 1614–1619. doi: 10.1016/j.ehj.2004.06.038
|
[5] |
Teixeira A, Parenica J, Park JJ, et al. Clinical presentation and outcome by age categories in acute heart failure: results from an international observational cohort. Eur J Heart Fail 2015; 17: 1114–1123. doi: 10.1002/ejhf.330
|
[6] |
Adams KF, Jr., Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100, 000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005; 149: 209–216. doi: 10.1016/j.ahj.2004.08.005
|
[7] |
Gheorghiade M, Abraham WT, Albert NM, et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 2006; 296: 2217–2226. doi: 10.1001/jama.296.18.2217
|
[8] |
Nieminen MS, Brutsaert D, Dickstein K, et al. EuroHeart Failure Survey Ⅱ (EHFS Ⅱ): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 2006; 27: 2725–2736. doi: 10.1093/eurheartj/ehl193
|
[9] |
Maggioni AP, Dahlstrom U, Filippatos G, et al. EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail 2010; 12: 1076–1084. doi: 10.1093/eurjhf/hfq154
|
[10] |
Oliva F, Mortara A, Cacciatore G, et al. Acute heart failure patient profiles, management and in-hospital outcome: results of the Italian Registry on Heart Failure Outcome. Eur J Heart Fail 2012; 14: 1208–1217. doi: 10.1093/eurjhf/hfs117
|
[11] |
Zannad F, Mebazaa A, Juilliere Y, et al. Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study. Eur J Heart Fail 2006; 8: 697–705. doi: 10.1016/j.ejheart.2006.01.001
|
[12] |
Chioncel O, Vinereanu D, Datcu M, et al. The Romanian Acute Heart Failure Syndromes (RO-AHFS) registry. Am Heart J 2011; 162: 142–153.e141. doi: 10.1016/j.ahj.2011.03.033
|
[13] |
Spinar J, Parenica J, Vitovec J, et al. Baseline characteristics and hospital mortality in the Acute Heart Failure Database (AHEAD) Main registry. Crit Care 2011; 15: R291. doi: 10.1186/cc10584
|
[14] |
Sato N, Kajimoto K, Keida T, et al. Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND Registry). Circ J 2013; 77: 944–951. doi: 10.1253/circj.CJ-13-0187
|
[15] |
Atherton JJ, Hayward CS, Wan Ahmad WA, et al. Patient characteristics from a regional multicenter database of acute decompensated heart failure in Asia Pacific (ADHERE International-Asia Pacific). J Card Fail 2012; 18: 82–88. doi: 10.1016/j.cardfail.2011.09.003
|
[16] |
Follath F, Yilmaz MB, Delgado JF, et al. Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM- HF). Intensive Care Med 2011; 37: 619–626. doi: 10.1007/s00134-010-2113-0
|
[17] |
Steinberg BA, Zhao X, Heidenreich PA, et al. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes. Circulation 2012; 126: 65–75. doi: 10.1161/CIRCULATIONAHA.111.080770
|
[18] |
Zhang J, Zhang Yh.[China Heart Failure Registry Study-A Multicenter, Prospective Investigation for Preliminary Analysis on Etiology, Clinical Features and Treatment in Heart Failure Patients]. Chin Circ J 2015; 30: 413–416.[Article in Chinese]. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgxhzz201505002
|
[19] |
https://data.worldbank.org.cn/ (accessed July 24, 2005).
|
[20] |
https://data.worldbank.org.cn/indicator/SP.DYN.LE00.IN?locations=MO-US-EU (accessed July 24, 2005).
|
[21] |
Ambrosy AP, Fonarow GC, Butler J, et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol 2014; 63: 1123–1133. doi: 10.1016/j.jacc.2013.11.053
|
[22] |
Lourenco AP, Leite-Moreira AF, Balligand JL, et al. An integrative translational approach to study heart failure with preserved ejection fraction: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology. Eur J Heart Fail 2018; 20: 216–227. doi: 10.1002/ejhf.1059
|
[23] |
Komajda M, Hanon O, Hochadel M, et al. Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey Ⅱ. Eur Heart J 2009; 30: 478–486. http://www.ncbi.nlm.nih.gov/pubmed/19106198
|
[24] |
Gattis WA, O'Connor CM, Gallup DS, et al. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial. J Am Coll Cardiol 2004; 43: 1534–1541. doi: 10.1016/j.jacc.2003.12.040
|
[25] |
Bavishi C, Ather S, Bambhroliya A, et al. Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions. Am J Cardiol 2014; 113: 1834–1838. doi: 10.1016/j.amjcard.2014.03.017
|
[26] |
Gheorghiade M, Abraham WT, Albert NM, et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J 2007; 28: 980–988. doi: 10.1093/eurheartj/ehl542
|
[27] |
Gheorghiade M, Rossi JS, Cotts W, et al. Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. Arch Intern Med 2007; 167: 1998–2005. doi: 10.1001/archinte.167.18.1998
|
[28] |
Klein L, O'Connor CM, Leimberger JD, et al. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study. Circulation 2005; 111: 2454–2460. doi: 10.1161/01.CIR.0000165065.82609.3D
|